Clinical Trials
3 trialsNCT02954874 2026-06-03
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00632047 2013-08-26
Early Detection of Breast Cancer and Cervical Cancer in Women in India
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01666171 2013-07-10
Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32
National Cancer Institute (NCI)
Unknown